Kýpur - gríska - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

mylan pharmaceuticals limited (0000011757) damastown industrial park, damastown rd, parslick, dublin, d15 xd71 - sildenafil citrate - film coated tablets - 50mg - sildenafil citrate (8000001620) 70,241mg

Evrópusambandið - gríska - EMA (European Medicines Agency)

mylan ire healthcare limited - pretomanid - Φυματίωση, ανθεκτική σε πολλαπλά φάρμακα - Αντιμικροβακτηριδια - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). Πρέπει να ληφθούν υπόψη οι επίσημες οδηγίες για την κατάλληλη χρήση των αντιβακτηριακών παραγόντων.

Evrópusambandið - gríska - EMA (European Medicines Agency)

mylan ireland limited - οξική απιρατερόνη - Νεοπλάσματα του προστάτη - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Evrópusambandið - gríska - EMA (European Medicines Agency)

mylan ireland limited - sugammadex sodium - Νευρομυϊκή παρεμπόδιση - Όλα τα άλλα θεραπευτικά προϊόντα - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Evrópusambandið - gríska - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - Σακχαρώδης διαβήτης τύπου 2 - Φάρμακα που χρησιμοποιούνται στον διαβήτη - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. θεραπεία τριπλού συνδυασμού) ως επιπρόσθετο στη δίαιτα και την άσκηση σε ασθενείς που δεν ελέγχονται επαρκώς με μέγιστη ανεκτή για αυτούς δόση μετφορμίνης και σουλφονυλουρίας. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Evrópusambandið - gríska - EMA (European Medicines Agency)

mylan ireland limited - φουμαρικό διμεθύλιο - Η Σκλήρυνση Κατά Πλάκας, Υποτροπιάζουσα-Διαλείπουσα - Ανοσοκατασταλτικά - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Evrópusambandið - gríska - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - Η Σκλήρυνση Κατά Πλάκας, Υποτροπιάζουσα-Διαλείπουσα - Ανοσοκατασταλτικά - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Evrópusambandið - gríska - EMA (European Medicines Agency)

viatris limited - Η πιρφενιδόνη - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - Ανοσοκατασταλτικά - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Evrópusambandið - gríska - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - Φάρμακα που χρησιμοποιούνται στον διαβήτη - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 και 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.